InvestorsObserver is giving Aligos Therapeutics Inc (ALGS) an Analyst Rating Rank of 15, meaning ALGS is ranked higher by analysts than 15% of stocks. The average price target for ALGS is $4.9 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ALGS a Buy today. Find out what this means to you and get the rest of the rankings on ALGS!